Overton T G, Lighten A D, Fisk N M, Bennett P R
Royal Postgraduate Medical School, Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, United Kingdom.
Am J Obstet Gynecol. 1996 Aug;175(2):382-7. doi: 10.1016/s0002-9378(96)70150-3.
We investigated whether reliable prenatal diagnosis is possible from fetal cells harvested transcervically in first-trimester pregnancies.
Fetal cells were obtained transcervically from 87 women undergoing pregnancy termination. Fetal gender was determined in 51 pregnancies with three different polymerase chain reaction techniques and in 36 pregnancies with fluorescent in situ hybridization. In known male pregnancies the number of male fetal cells present was also determined.
Polymerase chain reaction detected male deoxyribonucleic acid in up to 79% of cases in male pregnancies and up to 45% of cases in female pregnancies. Fetal gender was correctly predicted in up to 72% of cases with fluorescent in situ hybridization. However, fetal cells were identified in < 40% of informative male pregnancies and were present in low numbers-0.7% to 3.4% in swabs and 4.4% to 24.8% in flushes.
The use of fetal cells obtained by minimally invasive first-trimester transcervical sampling is unreliable for prenatal diagnosis.
我们研究了从孕早期经宫颈采集的胎儿细胞进行可靠的产前诊断是否可行。
从87例接受妊娠终止的妇女经宫颈获取胎儿细胞。采用三种不同的聚合酶链反应技术对51例妊娠进行胎儿性别鉴定,采用荧光原位杂交技术对36例妊娠进行胎儿性别鉴定。对于已知为男性的妊娠,还测定了其中存在的男性胎儿细胞数量。
聚合酶链反应在男性妊娠中高达79%的病例中检测到男性脱氧核糖核酸,在女性妊娠中高达45%的病例中检测到。荧光原位杂交在高达72%的病例中正确预测了胎儿性别。然而,在<40%的可提供信息的男性妊娠中识别出了胎儿细胞,且数量较少——拭子中为0.7%至3.4%,冲洗液中为4.4%至24.8%。
通过微创的孕早期经宫颈采样获取胎儿细胞用于产前诊断并不可靠。